Migraine Trial, Recruiting (NCT06409832)

Migraine Trial, Recruiting NCT06409832 Sponsor: University of Florence Condition: Migraine

Printed from Voxsanity (voxsanity.com.au) — NCT06409832 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Migraine

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with migraine (either with or without aura) based on recognised medical guidelines
You experience at least 4 days per month where you have a migraine
You are willing and able to follow the study's procedures and requirements
You have kept a headache diary covering at least the month before joining the study

Who may not be able to join:

You have a medical reason why you cannot take a type of migraine medication called "gepants" (confirm with trial site)
You have been diagnosed with chronic migraine (a more frequent, long-term form of migraine)
You have other health conditions or illnesses that, in the doctor's opinion, could affect the study results (confirm with trial site)
You are currently pregnant or breastfeeding
You have made any changes to your migraine prevention medications in the month before the study's first treatment would be given

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +393896969606

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06409832

Sponsor: University of Florence

Phase: Not Applicable

Status: Recruiting

Condition: Migraine

Trial contact: +393896969606

More information: https://clinicaltrials.gov/study/NCT06409832

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with migraine (either with or without aura) based on recognised medical guidelines
You experience at least 4 days per month where you have a migraine
You are willing and able to follow the study's procedures and requirements
You have kept a headache diary covering at least the month before joining the study

Who may not be able to join:

You have a medical reason why you cannot take a type of migraine medication called "gepants" (confirm with trial site)
You have been diagnosed with chronic migraine (a more frequent, long-term form of migraine)
You have other health conditions or illnesses that, in the doctor's opinion, could affect the study results (confirm with trial site)
You are currently pregnant or breastfeeding
You have made any changes to your migraine prevention medications in the month before the study's first treatment would be given

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Florence

Registry

ClinicalTrials.gov

Start date

26 March 2024

Est. completion

1 January 2027

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Changes in migraine frequency after three months of treatment; Percentage of 50% Responders (namely patients who presented a reduction of MMDs >/ = 50% compared to baseline) after three months of treatment with rimegepant

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov